12.03
price down icon0.17%   -0.02
after-market After Hours: 12.03
loading
Evolus Inc stock is traded at $12.03, with a volume of 534.67K. It is down -0.17% in the last 24 hours and down -17.55% over the past month.
See More
Previous Close:
$12.05
Open:
$11.7
24h Volume:
534.67K
Relative Volume:
0.71
Market Cap:
$778.30M
Revenue:
$202.09M
Net Income/Loss:
$-61.69M
P/E Ratio:
-11.14
EPS:
-1.08
Net Cash Flow:
$-35.64M
1W Performance:
-7.46%
1M Performance:
-17.55%
6M Performance:
-25.74%
1Y Performance:
-14.07%
1-Day Range:
Value
$11.61
$12.08
1-Week Range:
Value
$11.59
$13.10
52-Week Range:
Value
$9.25
$17.82

Evolus Inc Stock (EOLS) Company Profile

Name
Name
Evolus Inc
Name
Phone
(949) 284-4555
Name
Address
520 NEWPORT CENTER DRIVE, NEWPORT BEACH
Name
Employee
0
Name
Next Earnings Date
2025-03-04
Name
Latest SEC Filings
Name
EOLS's Discussions on Twitter

Compare EOLS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
EOLS
Evolus Inc
12.03 778.30M 202.09M -61.69M -35.64M -1.08
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
164.65 73.07B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.87 47.43B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.29 45.72B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.37 17.71B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
308.27 14.37B 2.76B 1.11B 898.10M 22.77

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-29-24 Upgrade Barclays Equal Weight → Overweight
Jun-23-22 Initiated Needham Buy
May-12-22 Upgrade Barclays Underweight → Equal Weight
Jan-20-22 Upgrade Truist Hold → Buy
May-06-21 Upgrade Mizuho Neutral → Buy
Apr-08-21 Reiterated H.C. Wainwright Buy
Feb-24-21 Downgrade Truist Buy → Hold
Jul-07-20 Downgrade Mizuho Buy → Neutral
Feb-06-20 Resumed Mizuho Buy
Nov-26-19 Initiated SVB Leerink Outperform
Sep-05-19 Resumed Mizuho Buy
Jun-28-19 Initiated Wells Fargo Market Perform
Jun-11-19 Initiated Barclays Underweight
Mar-20-19 Initiated SunTrust Buy
Feb-14-19 Initiated H.C. Wainwright Buy
Jan-29-19 Initiated Stifel Buy
View All

Evolus Inc Stock (EOLS) Latest News

pulisher
Mar 28, 2025

Evolus CEO David Moatazedi sells $77,512 in stock By Investing.com - Investing.com Australia

Mar 28, 2025
pulisher
Mar 28, 2025

Evolus CEO David Moatazedi sells $77,512 in stock - Investing.com India

Mar 28, 2025
pulisher
Mar 25, 2025

Evolus to Participate in The Needham 24th Annual Virtual Healthcare Conference - BioSpace

Mar 25, 2025
pulisher
Mar 25, 2025

Evolus Inc (EOLS) Shares Down 4.54% on Mar 25 - GuruFocus

Mar 25, 2025
pulisher
Mar 25, 2025

Evolus Leadership Reveals Growth Strategy at Major Healthcare Conference - Stock Titan

Mar 25, 2025
pulisher
Mar 24, 2025

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 21, 2025 - BioSpace

Mar 24, 2025
pulisher
Mar 23, 2025

Investing in Evolus (NASDAQ:EOLS) five years ago would have delivered you a 216% gain - Yahoo Finance

Mar 23, 2025
pulisher
Mar 21, 2025

Evolus reports inducement grants under Nasdaq listing rule 5635(C)(4) -March 21, 2025 at 04:17 pm EDT - MarketScreener

Mar 21, 2025
pulisher
Mar 21, 2025

Evolus director David Moatazedi sells $1.37 million in stock By Investing.com - Investing.com Australia

Mar 21, 2025
pulisher
Mar 21, 2025

Evolus Growth Continues: 14 New Employees Join as Company Strengthens Talent Pool - Stock Titan

Mar 21, 2025
pulisher
Mar 21, 2025

Evolus to Participate in Canaccord Genuity’s 43rd Annual Growth Conference - Business Wire

Mar 21, 2025
pulisher
Mar 20, 2025

Evolus executive Avelar Rui sells $369,867 in stock By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Evolus CFO Sandra Beaver sells $119,242 in company stock By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Evolus chief marketing officer sells $60,124 in common stock By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Evolus CFO Sandra Beaver sells $119,242 in company stock - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Evolus executive Avelar Rui sells $369,867 in stock - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Evolus director David Moatazedi sells $1.37 million in stock - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Evolus chief marketing officer sells $60,124 in common stock - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

When the Price of (EOLS) Talks, People Listen - news.stocktradersdaily.com

Mar 20, 2025
pulisher
Mar 20, 2025

Evolus Executives Sell Shares to Cover Tax Obligations - TradingView

Mar 20, 2025
pulisher
Mar 16, 2025

Trade Alert: Independent Director Of Evolus Karah Parschauer Has Sold Stock - Simply Wall St

Mar 16, 2025
pulisher
Mar 15, 2025

Demonstrates Effects Lasting 26 Weeks in Phase II Data Presented at 2023 ASDS Annual Meeting - Business Wire

Mar 15, 2025
pulisher
Mar 14, 2025

Evolus director Parschauer sells $167,465 in common stock - Investing.com India

Mar 14, 2025
pulisher
Mar 14, 2025

Evolus director Parschauer sells $167,465 in common stock By Investing.com - Investing.com South Africa

Mar 14, 2025
pulisher
Mar 13, 2025

Evolus’s SWOT analysis: fda approval boosts stock as dermal filler market expands - Investing.com India

Mar 13, 2025
pulisher
Mar 12, 2025

Evolus’s SWOT analysis: fda approval boosts stock as dermal filler market expands By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

Evolus at Barclays Conference: Strategic Growth and New Launch - Investing.com

Mar 12, 2025
pulisher
Mar 11, 2025

Evolus at Leerink’s Global Healthcare Conference: Strategic Growth Insights - Investing.com India

Mar 11, 2025
pulisher
Mar 11, 2025

Evolus at Leerink’s Global Healthcare Conference: Strategic Growth Insights By Investing.com - Investing.com Canada

Mar 11, 2025
pulisher
Mar 10, 2025

Mixue Group's Splashy Debut, Kroger's Change, Stuffed Crust Pizza, and Med Spas - The Motley Fool

Mar 10, 2025
pulisher
Mar 10, 2025

What is HC Wainwright’s Estimate for Evolus FY2025 Earnings? - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

(EOLS) Investment Analysis - Stock Traders Daily

Mar 09, 2025
pulisher
Mar 09, 2025

Evolus, Inc.: Navigating Financial Challenges Amidst Ongoing Losses and Market Uncertainty - MSN

Mar 09, 2025
pulisher
Mar 08, 2025

Global Jeuveau Market Outlook 2025-2034: Growth Drivers, Share, And Trends - EIN News

Mar 08, 2025
pulisher
Mar 08, 2025

Evolus, Inc. (NASDAQ:EOLS) Shares Acquired by Principal Financial Group Inc. - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Evolus, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Evolus, Inc. (NASDAQ:EOLS) Shares Acquired by Rhumbline Advisers - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

IFP Advisors Inc Has $52,000 Position in Evolus, Inc. (NASDAQ:EOLS) - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

Evolus’s Strong Market Position and Growth Potential Highlighted by Robust Revenues and Strategic Expansions - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

HC Wainwright Reaffirms “Buy” Rating for Evolus (NASDAQ:EOLS) - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Evolus’s Promising Growth and Strategic Positioning Earns a ‘Buy’ Rating from Analyst Douglas Tsao - TipRanks

Mar 06, 2025
pulisher
Mar 05, 2025

Evolus, Inc. Earnings Call Highlights Robust Growth and Profitability - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Evolus Inc Reports Q4 2024 Revenue of $79 Million, Surpassing Es - GuruFocus.com

Mar 05, 2025
pulisher
Mar 05, 2025

Stifel maintains Buy on Evolus stock, sets $25 target By Investing.com - Investing.com UK

Mar 05, 2025
pulisher
Mar 05, 2025

H.C. Wainwright maintains Buy rating on Evolus stock at $27 target By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

H.C. Wainwright maintains Buy rating on Evolus stock at $27 target - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

Evolus Celebrates Strong Demand For Jeuveau Wrinkle Treatment - Finimize

Mar 05, 2025
pulisher
Mar 05, 2025

Assessing Evolus: Insights From 6 Financial Analysts - Benzinga

Mar 05, 2025
pulisher
Mar 05, 2025

Evolus price target raised to $25 from $22 at Barclays - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Evolus reports Q4 EPS (11c) vs (21c) last year - TipRanks

Mar 05, 2025

Evolus Inc Stock (EOLS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$33.02
price down icon 0.57%
$97.60
price up icon 1.50%
$8.71
price up icon 0.35%
$110.60
price down icon 2.26%
$131.92
price up icon 0.08%
$308.27
price up icon 0.42%
Cap:     |  Volume (24h):